MORGAN STANLEY

Position in OTLK — Outlook Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in OTLK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$783

-$8,734 QoQ

Shares Held

3,806

-36.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 54 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.5517603783499737.ToString("F0")% Shared 0.ToString("F0")% None 99.44823962165003.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. OTLK ranks #470 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$783	3,806	-36.8%	Shares	Defined	2026-05-15
2025-12-31	$9,517	6,024	+677.3%	Shares	Defined	2026-05-27
2025-09-30	$821	775	-99.8%	Shares	Defined	2026-05-27
2025-06-30	$680,956	425,599	+978.2%	Shares	Defined	2025-08-15
2025-03-31	$48,156	39,474	-31.2%	Shares	Defined	2025-05-15
2024-12-31	$108,469	57,392	+31.2%	Shares	Defined	2025-05-15
2024-09-30	$233,511	43,729	+239.4%	Shares	Defined	2025-05-14
2024-06-30	$95,095	12,886	+7.6%	Shares	Defined	2025-05-14
2024-03-31	$142,955	11,973	—	Shares	Defined	2024-10-17
No filing history on record for this holder in this stock.